NCT00606879 Safety Study of SGX523, a Small Molecule Met Inhibitor, to Treat Solid Tumors Status TERMINATED Phase PHASE1
NCT00591890 Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans Status COMPLETED Phase PHASE1
NCT00591422 Phase I Study of Oral Darinaparsin (ZIO-101-C)in Advanced Solid Tumors and Non-Hodgkin's Lymphomas Status UNKNOWN Phase PHASE1
NCT00559182 A Study of MK-8033 in Patients With Advanced Solid Tumors (MK-8033-001) Status COMPLETED Phase PHASE1
NCT00551850 A Safety Study of an Oral EGFR Inhibitor, AV-412, Administered Three Times Weekly in Advanced Solid Tumor Patients Status COMPLETED Phase PHASE1
NCT00530907 Valproic Acid and Bevacizumab in Patients With Advanced Cancer Status COMPLETED Phase PHASE1
NCT00529230 Prevalence of Secondary Hypogonadism in Male Patients on Chronic Opioid Therapy for Cancer-Related Pain Syndromes Status TERMINATED Phase N/A
NCT00518739 MK2461 in Patients With Advanced Cancer (2461-001)(COMPLETED) Status COMPLETED Phase PHASE1
NCT00513162 Valproate and Etoposide for Patients With Neuronal Tumors and Brain Metastases Status COMPLETED Phase PHASE1
NCT00508326 Paclitaxel Administered by HAI to Patients With Advanced Cancer and Dominant Liver Involvement Status COMPLETED Phase PHASE1
NCT00507962 Cisplatin HAI Study in Patients With Advanced Cancer and Dominant Liver Involvement Status COMPLETED Phase PHASE1